Anna Åstrand




Matilda Backberg, Svante Vikingsson, Joakim Strandberg, Sara Wall, Anna Åstrand, Hanna Karlsson, Mattias Persson, Robert Kronstrand, Henrik Green (2023) Using in vitro receptor activity studies of synthetic cannabinoids to support the risk assessment of new psychoactive substances-A Swedish strategy to protect public health from harm Forensic Science International, Vol. 348, Artikel 111691 Vidare till DOI


Robert Kronstrand, Anna Åstrand, Shimpei Watanabe, Henrik Green, Svante Vikingsson (2021) Circumstances, Postmortem Findings, Blood Concentrations and Metabolism in a Series of Methoxyacetylfentanyl-Related Deaths Journal of Analytical Toxicology, Vol. 45, s. 760-771 Vidare till DOI
Anna Åstrand, Svante Vikingsson, Ingrid Jakobsen, Niclas Björn, Robert Kronstrand, Henrik Gréen (2021) Activation of the μ-opioid receptor by alicyclic fentanyls: Changes from high potency full agonists to low potency partial agonists with increasing alicyclic substructure Drug Testing and Analysis, Vol. 13, s. 169-174 Vidare till DOI


Per Ole M. Gundersen, Anna Åstrand, Henrik Gréen, Martin Josefsson, Olav Spigset, Svante Vikingsson (2020) Metabolite Profiling of Ortho-, Meta- and Para-Fluorofentanyl by Hepatocytes and High-Resolution Mass Spectrometry Journal of Analytical Toxicology, Vol. 44, s. 140-148 Vidare till DOI
Anna Åstrand, Davide Guerrieri, Svante Vikingsson, Robert Kronstrand, Henrik Green (2020) In vitro characterization of new psychoactive substances at the mu-opioid, CB1, 5HT(1A), and 5-HT2A receptors-On-target receptor potency and efficacy, and off-target effects Forensic Science International, Vol. 317, Artikel 110553 Vidare till DOI